William J. Sandborn's Insider Trades & SAST Disclosures
William J. Sandborn's most recent trade in Ventyx Biosciences Inc was a trade of 2,086 Common Stock done at an average price of $32.7 . Disclosure was reported to the exchange on Aug. 8, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern William J. Sandborn.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Sale of securities on an exchange or to another person at price $ 32.69 per share. | 08 Aug 2023 | 2,086 | 25,602 | - | 32.7 | 68,181 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Sale of securities on an exchange or to another person at price $ 33.12 per share. | 08 Aug 2023 | 1,408 | 24,194 | - | 33.1 | 46,628 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.85 per share. | 31 Jul 2023 | 11,900 | 60,289 | - | 14.9 | 176,715 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2023 | 11,900 | 676,200 | - | - | Stock Option (Right to Buy) | |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Sale of securities on an exchange or to another person at price $ 37.16 per share. | 31 Jul 2023 | 11,900 | 48,389 | - | 37.2 | 442,261 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 03 Jul 2023 | 11,900 | 48,389 | - | 40.0 | 476,014 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2023 | 11,900 | 688,100 | - | - | Stock Option (Right to Buy) | |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.85 per share. | 03 Jul 2023 | 11,900 | 60,289 | - | 14.9 | 176,715 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 03 Jul 2023 | 3,487 | 27,688 | - | 40 | 139,480 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Sale of securities on an exchange or to another person at price $ 34.26 per share. | 31 May 2023 | 10,629 | 48,389 | - | 34.3 | 364,155 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.20 per share. | 31 May 2023 | 10,629 | 59,018 | - | 0.2 | 2,126 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 10,629 | 10,790 | - | - | Stock Option (Right to Buy) | |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.20 per share. | 15 May 2023 | 3,272 | 38,149 | - | 0.2 | 654 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 3,272 | 20,922 | - | - | Stock Option (Right to Buy) | |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Sale of securities on an exchange or to another person at price $ 36.09 per share. | 15 May 2023 | 1,978 | 36,171 | - | 36.1 | 71,378 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Sale of securities on an exchange or to another person at price $ 36.88 per share. | 15 May 2023 | 1,309 | 34,862 | - | 36.9 | 48,273 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Sale of securities on an exchange or to another person at price $ 37.66 per share. | 15 May 2023 | 200 | 34,662 | - | 37.7 | 7,532 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 10,790 | 21,419 | - | - | Stock Option (Right to Buy) | |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.20 per share. | 28 Apr 2023 | 10,790 | 59,179 | - | 0.2 | 2,158 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Sale of securities on an exchange or to another person at price $ 37.40 per share. | 28 Apr 2023 | 6,904 | 48,389 | - | 37.4 | 258,185 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Sale of securities on an exchange or to another person at price $ 36.17 per share. | 28 Apr 2023 | 3,886 | 55,293 | - | 36.2 | 140,570 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Sale of securities on an exchange or to another person at price $ 33.87 per share. | 14 Dec 2022 | 21,760 | 48,389 | - | 33.9 | 737,085 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2022 | 20,922 | 3,272 | - | - | Stock Option (right to buy) | |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.20 per share. | 14 Dec 2022 | 20,922 | 55,799 | - | 0.2 | 4,184 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Sale of securities on an exchange or to another person at price $ 33.87 per share. | 14 Dec 2022 | 20,922 | 34,877 | - | 33.9 | 708,632 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2022 | 16,180 | 32,209 | - | - | Stock Option (right to buy) | |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.20 per share. | 14 Dec 2022 | 16,180 | 70,149 | - | 0.2 | 3,236 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.73 per share. | 14 Dec 2022 | 3,189 | 53,969 | - | 1.7 | 5,517 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2022 | 3,189 | 0 | - | - | Stock Option (right to buy) | |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.54 per share. | 14 Dec 2022 | 2,391 | 50,780 | - | 3.5 | 8,464 | Common Stock |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2022 | 2,391 | 0 | - | - | Stock Option (right to buy) | |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 700,000 | 700,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges